Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874039 · ClinicalTrials.gov registry record
Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis
A clinical trial of Atopic Dermatitis and Healthy Adults, sponsored by Northwestern University.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT03874039: Completed study of Atopic Dermatitis and Healthy Adults, sponsored by Northwestern University.
NCT03874039 is a study of Atopic Dermatitis and Healthy Adults that has completed, run by Northwestern University. The registered enrollment target is 20 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03874039, a study of Atopic Dermatitis and Healthy Adults, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Pilot study of a wearable gas and sweat skin sensor
Primary Outcome
Evaluation of protein contents from gas exudates from the skin
Conditions Studied
Interventions
- DEVICE Gas sensor
- DEVICE Sweat Sensor
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-01-15 |
| Est. Completion | 2021-08-10 |
What the finished NCT03874039 record still lists
NCT03874039 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (97% lower).
The record links to 5 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 2 interventions - of which Gas sensor is the first listed.
NCT03874039 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03874039 about?
NCT03874039 is a clinical study titled "Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis". Pilot study of a wearable gas and sweat skin sensor
What is the current status of trial NCT03874039?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-01-15. Estimated completion is 2021-08-10.
What conditions does trial NCT03874039 study?
This clinical trial studies the following conditions: Atopic Dermatitis, Healthy Adults, Wearables, Sweat Sensor, Gas Sensor.
What interventions are being tested in trial NCT03874039?
The interventions under investigation include: Gas sensor (DEVICE), Sweat Sensor (DEVICE).
Who is sponsoring clinical trial NCT03874039?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03874039 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03874039's enrollment target sits among peer trials
20 135th of 150 higher than 12 of 150 other Atopic Dermatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atopic Dermatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry for Systemic Eczema Treatments
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI